Italy's Recordati board finds CVC, GBL offer 'fair' as independent directors dissent
15/07/2026 23:10
Italy's Recordati board finds CVC, GBL offer 'fair' as independent directors dissent July 15 (Reuters) - Recordati RECI.MI said on Wednesday that a majority of its board has deemed as "fair" an offer by private equity firm CVC Capital Partners CVC.AS and Belgian investment group Groupe Bruxelles Lambert GBLB.BR to take the Italian drugmaker private.
Six out of the board's 10 members voted in favour of the €51.29 ($58.80) per share offer, while four independent directors deemed the offer to be inadequate and not fair, the company said in a statement.
($1 = 0.8723 euros)
(Reporting by Anusha Shah in Bengaluru; Editing by Chris Reese)
Recent news on Recordati Industria Chimica e Farmaceutica
See all newsItaly - Factors to watch on October 26
Deals of the day-Mergers and acquisitions
Brief: Recordati Says 66.67% Threshold Condition In Recordati Fulfilled
Brief: Recordati - CVC Capital Partners IX Aggregator Holds 19,189,219 Recordati Shares, 9.18% Of Share Capital
CVC, GBL hold 74.3% of Italian drugmaker Recordati at end of takeover offer period